Reports

Reports

• 2019
  • Addendum 1 to Deliverable 2 – Rider 60 Report Final Report on the Study of Potential Cost Savings in the Administration of Prescription Drug Benefits (PDF) (Mar. 2019)
• 2018
  • Evaluation of Pharmacy Service Delivery Models (Rider 23) (PDF) (Dec. 2018)
  • Prescription Drug Benefit Administration in Medicaid, CHIP, and Other Health-Related Services (Rider 60) (PDF) (Aug. 2018)
  • Annual Performance Report for the Prescription Drug Rebate Program (Rider 159) (PDF) (Aug. 2018)
• 2017
  • Clear Process for Including Prescription Drugs on the Texas Drug Code Index (Rider 204) (Nov. 2017)
  • Annual Performance Report for the Prescription Drug Rebate Program (Rider 23) (Aug. 2017)
  • State of Texas Vendor Drug Program Formulary Control State vs. MCO (Jan. 2017)
• 2016
  • Evaluation of Pharmacy Delivery Models (Rider 83) (PDF) (Dec. 2016)
  • Clinical and Economic Outcomes of the Texas Medicaid Medication Therapy Management Pilot: Asthma and COPD (Oct. 2016)
• 2015
  • Annual Performance Report for the Prescription Drug Rebate Program (Rider 24) (Dec. 2015)
  • Strengthening the Texas Medicaid Drug Utilization Review Program (Rider 49) (Nov. 2015)
  • Clinical and Economic Outcomes of the Texas Medicaid Medication Therapy Management Pilot (Sep. 2015)
  • Texas Pharmacy Ingredient Report (addendum) (PDF) (Mar. 2015)
  • CMS Annual Drug Utilization Review Report (FFY 2016)
• 2014
  • Cost of Dispensing Study (PDF) (Jun. 2014)
  • Texas Pharmacy Ingredient Report (PDF) (May 2014)
  • CMS Annual Drug Utilization Review Report (FFY 2015)

HHS Quarterly Drug Use and Expenditure Patterns

The quarterly use and expenditure pattern reports provide prescription drug use and expenditure information for the most prescribed individual drugs and therapeutic drug classes. Every quarter the state fiscal year (SFY)-to-date report is updated and a new set of quarterly reports is added.

Links

• HHS Reports and Presentations
• HHS Records and Statistics